Wilfried Rautenberg

Statistics

Publications

Citations

198

H-Index

Active since

2000

Affiliations

Merck KGaA, Darmstadt (Germany)(Current)

Wilfried Rautenberg is an author at Merck KGaA, Darmstadt (Germany) specializing in medicinal chemistry, 5-hydroxytryptamine receptor pharmacology, and 5-hydroxytryptamine 1a receptor agonists.

Publications per year

2000–2009

Publications

Sarizotan, a serotonin 5-HT 1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile

Gerd D. Bartoszyk, Christoph van Amsterdam, Hartmut E. Greiner et al. · Journal of Neural Transmission · 2004 · 75 citations

Medicine, Medicinal Chemistry, Pharmacology +16

5-HT Reuptake Inhibitors with 5-HT1B/1DAntagonistic Activity: A New Approach toward Efficient Antidepressants

Lisa Matzen, Christoph van Amsterdam, Wilfried Rautenberg et al. · Journal of Medicinal Chemistry · 2000 · 67 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Syntheses of novel 2,3-diaryl-substituted 5-cyano-4-azaindoles exhibiting c-Met inhibition activity

Hannes F. Koolman, Timo Heinrich, Henning Böttcher et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 29 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +13

New Selective and Potent 5-HT1B/1DAntagonists: Chemistry and Pharmacological Evaluation ofN-Piperazinylphenyl Biphenylcarboxamides and Biphenylsulfonamides

Yi Liao, Henning Böttcher, J. Harting et al. · Journal of Medicinal Chemistry · 2000 · 27 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

1–4 of 4